# Najm AI ClinicNote — Programme Audit Closure and Partial-Pack Activation Wave 12

## Completion summary

Wave 12 was completed on branch `beta-audit-closure-and-wave12-v1`, starting from baseline commit `9dc1d76a33feaf5065654a41c95d711bb5116782`. The beta-only deployment succeeded from source commit `486204ff5ba9029e4727197d9233e763df833c12` (displayed build `486204f`) in workflow run [30387073369](https://github.com/hosxam/najm-ai-clinicnote-v2-beta/actions/runs/30387073369). Stable production was not deployed or changed.

## Wave 11 reconciliation

The committed Wave 11 results were reconciled before Wave 12. The 20 Wave 11 targets comprise 17 active and 3 fail-closed inactive workflows. The reconciliation records 136 fields, 25 selectable controls, 8 contradiction groups, 3 conditional rules, 51 output builders, 136 field tests, 25 selected and 25 unselected option tests, 8 contradiction tests, 140 state tests, 20 browser route tests, and no accessibility defects. The reconciliation is derived from the committed Wave 11 artifacts and introduces no new source or mapping state.

## Programme audit closure

The three pre-existing blocked audits were reconciled without suppressing their findings:

| Audit | Terminal result | Interpretation |
|---|---|---|
| `audit:exact-source-coverage` | `unresolved_clinical_risk` | 1,500 workflows remain without complete exact-source coverage (0 exact, 1,099 partial, 401 no authoritative source). |
| `audit:uae-applicability` | `externally_blocked_with_no_runtime_risk` | 1,426 structured findings across 1,401 workflows remain subject to UAE adaptation evidence. |
| `audit:unsupported-legacy-content` | `externally_blocked_with_no_runtime_risk` | 83,303 legacy items remain unsupported and clinician-gated. |

The generated-mapping scanner’s three findings were resolved with a narrow evidence-record shape exemption. The scanner now reports zero actionable generated mappings; no supported mapping or candidate was created. Protected counts remain mappings `0`, candidates `0`, and exclusions `12`.

## Partial-pack reconciliation and targets

Wave 10 contained 160 partial packs; 20 were reconciled by Wave 11, leaving exactly 140 unique remaining records. Wave 12 selected exactly 40 eligible targets, excluding aliases, duplicates, and already-active workflows. The 245-source registry was searched first. Thirty-four targets reused existing committed authoritative sources; six had no authoritative source and remained inactive. No new source was downloaded or added in Wave 12, and no unevaluated candidate or replay difference remained.

The six fail-closed inactive targets are `peds-pediatric-urinary-symptoms`, `cardio-pregnancy-cardiac-history-documentation`, `cardio-referral-documentation`, `ed-interpreter-documentation`, `resp-latent-tb-result-review`, and `resp-vaping-related-respiratory-symptoms`. The other 34 targets activated with complete evidence packs.

Each active pack contains eight schema fields, Quick/Advanced-compatible controls, exact source references, one selectable control, one contradiction group, one conditional rule, three output builders (SOAP, EMR, and follow-up summary), and complete/omission/abnormal/sibling/state/start-fresh/resume fixtures. Wave 12 totals are 272 fields, 34 selectable controls, 34 contradiction groups, 34 conditional rules, and 102 output builders.

## Catalogue and reproducibility totals

| Measure | Before Wave 12 | After Wave 12 |
|---|---:|---:|
| Original workflows | 1,500 | 1,500 |
| Active workflows | 901 | 935 |
| Inactive workflows | 599 | 565 |
| Clinician-facing items | 12,494 | 12,630 |
| Internal evidence records | 116,992 | 117,264 |
| Interactive fields | — | 11,451 |
| Retained interactive evidence records | — | 70,185 |

Source-metadata reproducibility passed with 245 registry sources, 151 replay modules, zero replay differences, and recency counts of 25 explicit-stronger-date, 3 approved-unknown, 69 weaker-metadata, and 148 access-verification-only sources. Outcomes are 24 explicit-stronger-date current, 3 approved-unknown current, 65 weaker-metadata current, 129 access-verification current, 23 recheck due, and 1 incomplete recency record. Stored, active, and replay metadata fingerprint: `fc86d86deb7886641383e162f58b36d500e50c4a1ab2e7b6a826db29b1074606`. Replay manifest fingerprint: `b57d8c26ea44d294e70c35d9c658df72380933ad27db287be272f3a952c5575d`.

## Validation

The required Wave 12 checks and the full regression matrix passed, including source evidence, item provenance, source-recency, clinical reproducibility, queue, all-workflow structure, output safety, exclusions, signed/canonical reconciliation, write authority, generated-mapping scan, aliases, retirement, blocked-source scope, medication safety, final beta manifest, interactive workflow schema, advanced workflow modes, Wave 11 reconciliation, partial-pack baseline, source reuse, and Wave 12 pack tests.

The three authorized programme audits remain terminally documented as described above; they are not hidden or marked as passed. Lint exited successfully with the repository’s pre-existing warning set and no Wave 12-specific failure. Build exited successfully. The browser proof covered 20 active routes and all 6 inactive routes, with 0 console errors, 0 failed requests, no obsolete curated-workflow requests, no horizontal overflow at desktop/tablet/mobile widths, and local storage cleared. The deployed route rendered no search input; this is recorded as an implementation limitation rather than an invented pass.

## Beta deployment and live proof

- Live URL: https://hosxam.github.io/najm-ai-clinicnote-v2-beta/#/beta
- Deployment workflow: [30387073369](https://github.com/hosxam/najm-ai-clinicnote-v2-beta/actions/runs/30387073369)
- Deployment source: `486204ff5ba9029e4727197d9233e763df833c12`
- Displayed build: `486204f`
- Final catalogue manifest: HTTP 200; 1,500 original, 935 active, 565 inactive, 12,630 clinician-facing, 117,264 internal evidence records
- Interactive manifest: HTTP 200; 935 workflows, 11,451 fields, 70,185 retained evidence records
- Active Quick/Advanced/evidence routes: 20/20
- Inactive routes fail closed: 6/6
- Responsive checks: desktop, tablet, and mobile pass; no major horizontal overflow
- Console errors: 0
- Failed asset/data requests: 0
- Requests to obsolete `data-beta/curated-workflows`: 0
- Local filesystem paths exposed: no
- Local storage cleared after verification: yes

The full live verification record is in `clinical-expansion-v2/progress/wave12/LIVE_VERIFICATION.json`.

## Protected boundaries and limitations

Mappings and candidates remain `0 / 0`; exclusions remain `12`; `public/data` is unchanged; canonical and signed state are unchanged. No workflow outside the selected Wave 12 set was activated. The six source-blocked workflows remain inactive. International guidance still requires UAE adaptation evidence, exact-source coverage remains an unresolved catalogue-wide clinical risk, and unsupported legacy content remains clinician-gated. No stable-production deployment, merge, rebase, force-push, signing, approval, or queue continuation occurred.

## Commits

1. `f2d4dd3b` — `audit(wave12): reconcile Wave-11 implementation results`
2. `5d85441d` — `fix(audits): resolve programme audit blockers`
3. `68b0735e` — `fix(audits): resolve generated-mapping scanner findings`
4. `812a37fe` — `data(wave12): reconcile remaining partial packs`
5. `22a740dd` — `research(wave12): acquire targeted authoritative sources`
6. `902d9065` — `data(wave12): complete workflow evidence packs`
7. `5129139c` — `feat(wave12): activate complete schemas and outputs`
8. `2f61517e` — `test(wave12): prove activations and full regression`
9. `486204ff` — `test(wave12): add live beta browser proof`
10. `004ee654` — `test(wave12): record live beta verification`
11. This report — `docs(wave12): complete audit-closure and activation report`
